west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "持续性肺漏气" 2 results
  • 白介素-2在肺切除术后持续性肺漏气治疗中的应用

    目的 观察经胸腔引流管灌注白介素-2治疗肺切除术后持续性肺漏气的临床疗效,探讨该方法在临床治疗中的应用价值。 方法 2012年1月-12月对26例肺切除术后持续性肺漏气患者行白介素-2胸膜腔灌注,观察其疗效及不良反应情况。 结果 15例Ⅰ级漏气、6例Ⅱ级漏气患者经1 次灌注重组人白介素-2后治愈;3例Ⅱ级漏气及1例Ⅲ级漏气经两次注药后治愈;1例Ⅲ级漏气者行3次注药后治愈。从第1次注射药至肺漏气停止时间为1 h~5 d,平均1.3 d。2例出现注药后低热,未观察到其他相关并发症发生。 结论 经胸腔引流管灌注重组人白介素-2治疗肺切除术后持续性肺漏气,其疗效确切,不良反应发生率低,可作为治疗持续性肺漏气的有效方法。

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
  • Research progress on autologous blood patch pleurodesis

    Autologous blood patch pleurodesis (ABPP) was first proposed in 1987. Now it is mainly used to treat intractable pneumothorax and persistent pneumothorax after pneumonectomy, and also used to treat pneumothorax in children and other rare secondary pneumothorax. Persistent air leakage and pneumothorax of various causes are essentially alveolar pleural fistula. It can usually be treated by closed thoracic drainage, continuous negative pressure suction and surgery. Pleurodesis is a safe and effective alternative to surgery for patients who have failed conventional conservative treatment and can not be operated. Compared with other pleurodesis adhesives, using autologous blood (ABPP) is safer and more effective, and it is simple, painless, cheap and easy to be accepted by patients. But in the domestic and foreign researches in recent years, many details of ABPP treatment have not been standardized. For further research and popularization, this article reviews the detailed regulations, efficacy and safety of ABPP.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content